Kohn L D, Shimura H, Shimura Y, Hidaka A, Giuliani C, Napolitano G, Ohmori M, Laglia G, Saji M
Laboratory of Biochemistry and Metabolism, National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892.
Vitam Horm. 1995;50:287-384. doi: 10.1016/s0083-6729(08)60658-5.
This chapter has outlined the complex process required for thyroid growth and function. Both events are regulated by TSHR via a multiplicity of signals, with the aid of and requirement for a multiplicity of hormones that regulate the TSHR via receptor cross-talk: insulin, IGF-I, adrenergic receptors, and purinergic receptors. Cross-talk appears to regulate G-protein interactions or activities induced by TSH as well as TSHR gene expression. The TSHR structure and its mechanism of signal transduction is being rapidly unraveled in several laboratories, since the recent cloning of the receptor. In addition, the epitopes for autoantibodies against the receptor that can subvert the normal regulated synthesis and secretion of thyroid hormones, causing hyper- or hypofunction, have been defined. Studies of regulation of the TSHR minimal promotor have uncovered a better understanding of the mechanisms by which TSH regulates both growth and function of the thyroid cell. A key novel component of this phenomenon involves TSH AMP positive and negative regulation of the TSHR. Negative transcriptional regulation is a common feature of MHC class I genes in the thyroid. Subversion of negative regulation or too little negative regulation is suggested to result in autoimmune disease. Methimazole and iodide at autoregulatory levels may be important in reversing this process and returning thyroid function to normal. Their action appears to involve factors that react with the IREs on both the TSHR and the TG promoter. Too much negative regulation, as in the case of ras transformation, results in abnormal growth without function. TTF-1 is implicated as a critical autoregulatory component in both positive and negative regulation of the TSHR and appears to be the link between TSH, the TSHR, TSHR-mediated signals, TG and TPO biosynthesis, and thyroid hormone formation. Differentially regulated expression of the TSHR and TG by cAMP and insulin depend on differences in the specificity of the TTF-1 site, that is, the lack of Pax-8 interactions with the TSHR, and the IRE sites. Single-strand binding proteins will become important in determining how TSHR transcription is controlled mechanistically.
本章概述了甲状腺生长和功能所需的复杂过程。这两个过程均由促甲状腺激素受体(TSHR)通过多种信号进行调节,同时还借助多种通过受体间相互作用来调节TSHR的激素,这些激素包括胰岛素、胰岛素样生长因子-I(IGF-I)、肾上腺素能受体和嘌呤能受体。受体间相互作用似乎可调节促甲状腺激素(TSH)诱导的G蛋白相互作用或活性以及TSHR基因表达。自受体最近被克隆以来,多个实验室正在迅速揭示TSHR的结构及其信号转导机制。此外,已确定了针对该受体的自身抗体的表位,这些自身抗体可破坏甲状腺激素的正常调节合成和分泌,导致甲状腺功能亢进或减退。对TSHR最小启动子调控的研究,使人们对TSH调节甲状腺细胞生长和功能的机制有了更深入的了解。这一现象的一个关键新成分涉及TSH对TSHR的正负调控。负转录调控是甲状腺中MHC I类基因的一个共同特征。负调控的破坏或负调控过少被认为会导致自身免疫性疾病。自调节水平的甲巯咪唑和碘化物在逆转这一过程并使甲状腺功能恢复正常方面可能很重要。它们的作用似乎涉及与TSHR和甲状腺球蛋白(TG)启动子上的铁反应元件(IRE)相互作用的因子。负调控过多,如在ras转化的情况下,会导致无功能的异常生长。甲状腺转录因子-1(TTF-1)被认为是TSHR正负调控中的关键自调节成分,似乎是TSH、TSHR、TSHR介导的信号、TG和甲状腺过氧化物酶(TPO)生物合成以及甲状腺激素形成之间的联系。cAMP和胰岛素对TSHR和TG的差异调节表达取决于TTF-1位点特异性的差异,即缺乏配对盒8(Pax-8)与TSHR以及IRE位点的相互作用。单链结合蛋白在确定TSHR转录的机械控制方式方面将变得很重要。